Augustine Asset Management’s United Therapeutics UTHR Stock Holding History

Augustine Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.38M	Buy	9,920 +28	+0.3%	+$14.5K	1.16%	21
2026 Q2	$5.36M	Buy	9,892 +3,919	+66%	+$2.21M	1.09%	19
2026 Q1	$3.54M	Buy	5,973 +39	+0.7%	+$19.4K	0.8%	24
2025 Q4	$2.89M	Sell	5,934 -554	-9%	-$258K	0.58%	29
2025 Q3	$2.72M	Buy	6,488 +1,206	+23%	+$406K	0.55%	27
2025 Q2	$1.52M	Buy	+5,282	New	+$1.58M	0.41%	39

Other funds holding UTHR

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

VFP

Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $10.1B AUM 30.4% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return

Augustine Asset Management's UTHR Position: Q3 2026 in Review

Augustine Asset Management increased its United Therapeutics (UTHR) stake by 0.28% in Q3 2026, buying an estimated $14.5K and bringing the position to 9,920 shares worth $5.38M. The position accounts for 1.16% of the portfolio, ranked #21.

Augustine Asset Management first reported a position in UTHR in Q2 2025 and has held it in 6 quarters since. 117 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

Augustine Asset Management held 9,920 shares of United Therapeutics worth $5.38M as of Q3 2026.
Augustine Asset Management bought 28 United Therapeutics shares in Q3 2026, an estimated $14.5K.
United Therapeutics made up 1.16% of Augustine Asset Management's portfolio in Q3 2026, its #21 holding.
Augustine Asset Management first reported a position in United Therapeutics in Q2 2025 and has held it in 6 quarters since.
117 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Augustine Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.